What's breaking now, across thousands of outlets.
Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer's and other dementias.
We haven't written up this one. The Hill has the full story — the link below goes straight to it.
Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer.
The first death occurred in March and the last just nine days ago. Mothers say there are still four infected babies at the Gynecology-Obstetrics Hospital of the Western National Medical Center in…
New Delhi, October 8, 2026: The Centre has decided to cap trade margins at 30 per cent of maximum retail price for all non-scheduled anti-cancer drugs, covering branded and generic, domestic and…
(MedPage Today) -- With federal vaccine policy and infectious disease research undergoing major changes, professional medical societies are stepping in to fill gaps once occupied by federal health…
Russia's handling of the suspected case fits a broader pattern of concealing information about dangerous incidents, Andrii Sybiha said.
New Delhi, October 8, 2026: The Supreme Court on Thursday, October 8, directed the Centre to constitute a committee to recommend measures to curb unethical marketing practices by pharmaceutical…
